3 Consumer Staples Stocks to Buy Before the End of June
Consumer confidence is softening into the back half of spring, and the rotation out of growth and into recession-resistant cash flow is picking up speed. For investors looking to add ballast before the summer, three blue-chip staples stand out: Each…
Consumer confidence is softening into the back half of spring, and the rotation out of growth and into recession-resistant cash flow is picking up speed. For investors looking to add ballast before the summer, three blue-chip staples stand out: Each delivered a top-and-bottom-line beat in its most recent quarter, each carries a multi-decade dividend track record and each is rated a Buy by our model with double-digit (or near-double-digit) upside to base-case targets.
Here are three defensive compounders worth a look in June.
Coca-Cola (NYSE: KO)
Coca-Cola (NYSE:KO | KO Price Prediction) is the cleanest summer trade in the group. Beverages skew warm-weather, and the company is heading into peak season with serious momentum. Q1 2026 (filed April 28) delivered EPS of 86 cents against an 81-cent estimate and revenue of $12.472 billion, up 12% year over year. Organic revenue growth ran at 10%, global unit case volume rose 3%, and Coca-Cola Zero Sugar volume jumped 13% across all geographic segments.
Operating margin expanded to 35% from 33%, and management raised comparable EPS growth guidance to 8% to 9% versus the $3.00 baseline in 2025, with free cash flow targeted near $12.2 billion. New CEO Henrique Braun said, “We’ve had a strong start to the year. Our performance this quarter reflects our unwavering focus on staying close to the consumer, executing locally and managing complexity.”
At around $84, shares trade at a forward P/E of 24 with a 3% dividend yield backed by a 63rd consecutive annual increase. Our model targets $90.13 base case with 8% upside, supported by 79% bullish analysts.
The caveat: Asia Pacific comparable operating income declined 17% in Q1, and the pending Coca-Cola Beverages Africa sale creates a roughly 4% headwind on net revenues.
Procter & Gamble (NYSE: PG)
Procter & Gamble (NYSE:PG) is the laggard turning the corner. Shares are down 6% over the past year but have rebounded 6% in the past week, suggesting the rotation trade is already pulling capital into this name. The Q3 FY2026 report (filed April 24, 2026) showed core EPS of $1.59 versus $1.5552 expected on net sales of $21.235 billion, up 7% year over year. Organic growth of 3% came in broad-based across all five segments, with Beauty leading at 7% organic growth.
The summer angle is structural. Deodorants, laundry, paper, and skin care peak in the warm months, and P&G’s brand stable, including Tide, Pampers, Gillette, Olay, and Charmin, prints reliable cash regardless of macro stress. Management is funneling that cash back to shareholders aggressively: about $10 billion in dividends and $5 billion in repurchases for FY2026, on top of a 70th consecutive annual dividend increase and 136th straight year of dividend payments since 1890.
At around $149, PG trades at a forward P/E of 21 with a 3% yield. Our base case sees $165.63, or 11% upside. CEO Shailesh Jejurikar noted P&G is “increasing investments to accelerate momentum with consumers despite the challenging geopolitical and economic environment.”
The caveat: a roughly $400 million after-tax tariff headwind plus $150 million in commodity costs have management guiding to the lower end of the $6.83 to $7.09 core EPS range.
Colgate-Palmolive (NYSE: CL)
Colgate-Palmolive (NYSE:CL) carries the highest model-implied upside in this trio. Q1 2026 (filed May 1) produced adjusted EPS of 97 cents versus the 94-cent consensus on revenue of $5.32 billion, up 8.4% year over year. Organic sales grew 3%, with Latin America up 15%, Europe up 12%, and Asia Pacific up 9%. CEO Noel Wallace called it a “strong start to 2026, with broad-based top and bottom-line growth.”
The summer angle layers nicely: Speed Stick and Irish Spring for personal care, EltaMD for skin, and Hill’s Science Diet for pet travel. Hill’s Pet Nutrition grew 7% in the quarter. Colgate is a Dividend Aristocrat with 63 consecutive years of annual dividend increases and returned $2.9 billion to shareholders in 2025.
At around $89, the stock yields 2% with a forward P/E of 23. Our model targets $105.51 with 17% upside, anchored by a 0.32 beta and 65% bullish analyst sentiment with zero sell ratings.
The caveat: tariffs forced a downward revision to GAAP gross margin guidance, North America organic sales declined 2% with volume off 3%, and the SGPP restructuring program expanded to $350 to $550 million in cumulative charges.
What Investors Should Watch Next
All three names share a profile that suits the current setup: low beta, broad-based organic growth, multi-decade dividend records, and consistent earnings beats. Coca-Cola offers the cleanest seasonal volume story, P&G the deepest dividend pedigree at the most reasonable forward multiple, and Colgate the highest model-implied upside. Watch June quarter prints from each and the trajectory of tariff costs for the household products names: that is where the next leg of guidance gets reset.
Contact [email protected] for any questions or corrections.
Joel South covers large-cap stocks, dividend investing, and major market trends, with a focus on earnings analysis, valuation, and turning complex data into actionable insights for investors.
He brings more than 15 years of experience as an investor and financial journalist, including 12 years at The Motley Fool, where he served as an investment analyst, Bureau Chief, and later led the Fool.com investing news desk. He has also co-hosted an investing podcast and appeared across TV and radio discussing market trends.
